The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|March 31, 2023
Insights into the Medical Cannabis Track with Cannabis Science Conference Program Chair Cherissa Jackson
Author(s)Erin McEvoy
What is Cherissa Jackson, RN most excited about as the medical track program chair for Cannabis Science Conference?
Advertisement
Listen as "America's Combat Nurse" Cherissa Jackson, CEO/Founder of WE DECODE LLC, shares how she envisions the medical track for the 2023 conference.
Join the conversation around medical cannabis! Register here to attend Cannabis Science Conference Spring, April 19-21 in Portland, Oregon:
Advertisement
Related to this article
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.
Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.
Advertisement
Advertisement